4.5 Article

rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy

Kazuhiko Kurozumi et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Biotechnology & Applied Microbiology

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

Caroline J. Breitbach et al.

MOLECULAR THERAPY (2007)

Article Biotechnology & Applied Microbiology

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma

F Benencia et al.

HUMAN GENE THERAPY (2005)

Review Immunology

Viral mimicry of cytokines, chemokines and their receptors

A Alcami

NATURE REVIEWS IMMUNOLOGY (2003)

Review Immunology

Viral evasion of natural killer cells

JS Orange et al.

NATURE IMMUNOLOGY (2002)

Article Immunology

Leukotrienes play protective roles early during experimental VSV encephalitis

NN Chen et al.

JOURNAL OF NEUROIMMUNOLOGY (2001)

Review Immunology

NK cells and NKT cells in innate defense against viral infections

CA Biron et al.

CURRENT OPINION IN IMMUNOLOGY (2001)

Article Multidisciplinary Sciences

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

T Todo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Biochemistry & Molecular Biology

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

DF Stojdl et al.

NATURE MEDICINE (2000)

Review Biotechnology & Applied Microbiology

Cellular receptors for viruses: links to tropism and pathogenesis

J Schneider-Schaulies

JOURNAL OF GENERAL VIROLOGY (2000)

Article Immunology

A broad spectrum secreted chemokine binding protein encoded by a herpesvirus

CM Parry et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2000)